Edition:
United Kingdom

Corvus Pharmaceuticals Inc (CRVS.OQ)

CRVS.OQ on NASDAQ Stock Exchange Global Market

10.86USD
12 Dec 2017
Change (% chg)

$-0.09 (-0.82%)
Prev Close
$10.95
Open
$10.99
Day's High
$11.04
Day's Low
$10.75
Volume
15,713
Avg. Vol
19,391
52-wk High
$22.01
52-wk Low
$8.27

Latest Key Developments (Source: Significant Developments)

Corvus Pharmaceuticals reports third quarter 2017 financial results
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Corvus Pharmaceuticals Inc ::Corvus Pharmaceuticals reports third quarter 2017 financial results and clinical program update.Net loss for three months ended September 30, 2017, was $12.7 million compared to $10.3 million for same period in 2016​.  Full Article

Corvus Pharma qtrly loss per share $0.43
Thursday, 4 Aug 2016 

Corvus Pharmaceuticals Inc : Corvus pharmaceuticals announces second quarter financial results and provides business update . Q2 earnings per share view $-0.36 -- Thomson Reuters I/B/E/S .Qtrly loss per share $0.43.  Full Article

Corvus Pharmaceuticals announces pricing of initial public offering
Tuesday, 22 Mar 2016 

Corvus Pharmaceuticals:Says pricing of its initial public offering of 4,700,000 shares of its common stock at an initial public offering price of $15.00 per share.Shares are expected to begin trading on The NASDAQ Global Market on March 23, 2016 under the ticker symbol CRVS.Offering is expected to close on March 29.  Full Article

BRIEF-Corvus Pharmaceuticals reports third quarter 2017 financial results

* Corvus Pharmaceuticals reports third quarter 2017 financial results and clinical program update